Hemofilia – Revista Farmacéuticos https://www.farmaceuticos.com/revista Tue, 11 Jun 2024 07:18:45 +0000 es hourly 1 https://wordpress.org/?v=6.5 https://www.farmaceuticos.com/revista/wp-content/uploads/2024/02/cropped-favi-cion-farmaceuticos-1-32x32-1.png Hemofilia – Revista Farmacéuticos https://www.farmaceuticos.com/revista 32 32 Emicizumab (Hemlibra®) en hemofilia A moderada sin inhibidores con fenotipo hemorrágico grave https://www.farmaceuticos.com/revista/medicamentos/emicizumab-hemlibra-en-hemofilia-a-moderada-sin-inhibidores-con-fenotipo-hemorragico-grave/ Fri, 03 May 2024 12:38:48 +0000 https://www.farmaceuticos.com/revista/?post_type=medicines&p=1342 Etranacogén dezaparvovec (Hemgenix®) en Hemofilia B grave y moderadamente grave https://www.farmaceuticos.com/revista/medicamentos/etranacogen-dezaparvovec-hemgenix-en-hemofilia-b-grave-y-moderadamente-grave/ Mon, 04 Dec 2023 17:16:07 +0000 https://www.farmaceuticos.com/revista/?post_type=medicines&p=1496 Valoctocogén roxaparvovec (Roctavian®) en hemofilia A grave https://www.farmaceuticos.com/revista/medicamentos/valoctocogen-roxaparvovec-roctavian-en-hemofilia-a-grave/ Sun, 03 Dec 2023 17:16:05 +0000 https://www.farmaceuticos.com/revista/?post_type=medicines&p=1495